-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 17th Enhua Pharmaceuticals announced that Medazolen injections had passed a consistent evaluation application, becoming the first manufacturer of the drug to evaluate the quality and efficacy of generic drugs.
1, intramyocardial or intravenous injections for preoperative sedation/anti-anxiety/memory loss.
2. Sedation/anti-anxiety/memory loss prior to or during intravenous injections for diagnosis, treatment, endoscopy (e.g. bronchial, gastroscopic, cystoscopy, coronary analtomy, cardiac catheterization, tumor surgery, radiation procedures, stitching lacerations and other individual medications or in association with other central nervous system inhibitors).
3, intravenous induction before the drug is administered with other anesthetics.
anaesthetic induction can be achieved in a relatively narrow dose range and in a short period of time with the use of anaesthetic pre-drug use.
intravenous medazole can also be used as an intravenous supplement for nitrous oxide and oxygen (composite anesthesia).
4, continuous intravenous drip medazoleon as an anesthetic for sedation of patients with tracheal intage and mechanical aeration, or for sedation in critical care treatment.
, Enhua has invested about RMB 3.61 million in research and development on the variety consistency evaluation project.
。
